Pages that link to "Q34660987"
Jump to navigation
Jump to search
The following pages link to Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial (Q34660987):
Displaying 50 items.
- Tuberculosis vaccines and prevention of infection (Q26782022) (← links)
- Recent advances in the development of vaccines for tuberculosis (Q26796440) (← links)
- Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy (Q26798372) (← links)
- Vaccine development for tuberculosis: current progress (Q26827737) (← links)
- Recent advances towards tuberculosis control: vaccines and biomarkers (Q26859739) (← links)
- Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis (Q26863391) (← links)
- Vaccines for TB: Lessons from the Past Translating into Future Potentials (Q26996673) (← links)
- Mycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human Tuberculosis (Q28083909) (← links)
- Current efforts and future prospects in the development of live mycobacteria as vaccines (Q28087077) (← links)
- Cell death and autophagy in tuberculosis (Q28387214) (← links)
- Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. (Q30361227) (← links)
- Novel vaccination strategies against tuberculosis. (Q30363188) (← links)
- Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice (Q33724934) (← links)
- Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults (Q34055234) (← links)
- Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis (Q34563543) (← links)
- Anergic pulmonary tuberculosis is associated with contraction of the Vd2+T cell population, apoptosis and enhanced inhibitory cytokine production (Q34926588) (← links)
- The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice (Q35043659) (← links)
- Vaccine against tuberculosis: what's new? (Q35101472) (← links)
- Animal models of tuberculosis: Guinea pigs (Q35663870) (← links)
- Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations (Q35826779) (← links)
- Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain (Q36145657) (← links)
- T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents (Q36260275) (← links)
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A (Q36369598) (← links)
- Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection (Q36511211) (← links)
- BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers (Q36838289) (← links)
- Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis (Q36974221) (← links)
- Current status of new tuberculosis vaccine in children (Q37130796) (← links)
- Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial (Q37239545) (← links)
- Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa (Q37633072) (← links)
- The BCG replacement vaccine VPM1002: from drawing board to clinical trial (Q38202181) (← links)
- Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory (Q38207991) (← links)
- Totally drug-resistant tuberculosis and adjunct therapies. (Q38210265) (← links)
- The present and future of tuberculosis vaccinations (Q38280134) (← links)
- Trained immunity: consequences for the heterologous effects of BCG vaccination (Q38312182) (← links)
- Aerosol immunisation for TB: matching route of vaccination to route of infection (Q38338183) (← links)
- T cells and adaptive immunity to Mycobacterium tuberculosis in humans (Q38363792) (← links)
- Mycobacterium tuberculosis virulence: insights and impact on vaccine development (Q38539493) (← links)
- Towards new TB vaccines: What are the challenges? (Q38767468) (← links)
- Mycobacterium tuberculosis infection and vaccine development. (Q38828636) (← links)
- Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines (Q38849791) (← links)
- Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis (Q38886409) (← links)
- Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis (Q38907507) (← links)
- The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation. (Q38928554) (← links)
- First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine (Q39020137) (← links)
- The BCG Strain Pool: Diversity Matters (Q39788557) (← links)
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial (Q40284715) (← links)
- Differential inflammasome activation signatures following intracellular infection of human macrophages with Mycobacterium bovis BCG or Trypanosoma cruzi. (Q40509134) (← links)
- The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection (Q40722193) (← links)
- BCG Vaccination Induces Robust CD4+ T Cell Responses to Mycobacterium tuberculosis Complex-Specific Lipopeptides in Guinea Pigs (Q40786879) (← links)
- The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses (Q41740656) (← links)